NYSE · BMEZ
BlackRock Health Sciences Term Trust
$17.79+$0.22 (+1.25%)
BlackRock Health Sciences Term Trust’s quoted price sits in the upper half of its reported 52-week range, 0.34% below the high.
Loading market information…
NYSE · BFK · USD
Stock price, dividends, earnings
Quote as of Feb 6, 2026, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
BlackRock Municipal Income Trust’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
BlackRock Municipal Income Trust’s forward annual dividend is $0.60 per share, paid monthly. The forward yield is 5.95% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow BlackRock Municipal Income Trust’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The BlackRock Municipal Income Trust operates as a closed-end mutual fund, initiated by BlackRock, Inc. Its management is overseen by BlackRock Advisors, LLC. The fund's investment strategy primarily targets the fixed income market, with a significant emphasis on high-quality municipal bonds designed to be exempt from standard federal income taxation. This trust was formed on July 31, 2001, and is based in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:07 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$17.79+$0.22 (+1.25%)
BlackRock Health Sciences Term Trust’s quoted price sits in the upper half of its reported 52-week range, 0.34% below the high.
$10.65+$0.21 (+2.01%)
Neuberger Energy Infrastructure and Income Fund Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.01% below the high.
$10.54-$0.02 (-0.19%)
BlackRock Municipal Income Trust II’s quoted price sits in the upper half of its reported 52-week range, 2.68% below the high.
$11.62+$0.09 (+0.74%)
BlackRock Limited Duration Income Trust’s quoted price sits in the lower half of its reported 52-week range, 17.59% below the high.
$22.23-$0.08 (-0.36%)
First Trust Enhanced Equity Income Fund’s quoted price sits in the upper half of its reported 52-week range, 6.68% below the high.
$9.97+$0.14 (+1.42%)
Eaton Vance Municipal Income Trust’s quoted price sits in the lower half of its reported 52-week range, 11.46% below the high.
$18.86+$0.22 (+1.18%)
Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.47% below the high.
$11.11-$0.04 (-0.36%)
BlackRock California Municipal Income Trust’s quoted price sits in the upper half of its reported 52-week range, 3.1% below the high.
